| NCT06126042 | Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route | RECRUITING | PHASE1 | 2023-10-03 | 2024-07 | 2024-04 |
| NCT04640233 | Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection | UNKNOWN | PHASE2, PHASE3 | 2020-11-30 | 2021-09 | 2021-08 |
| NCT04529499 | Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients | TERMINATED | PHASE3 | 2020-08-22 | 2021-01-27 | 2021-01-22 |
| NCT04268771 | A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products | COMPLETED | PHASE3 | 2020-04-08 | 2022-04-20 | 2022-01-26 |
| NCT03976102 | Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma | COMPLETED | PHASE3 | 2019-05-15 | 2023-02-27 | 2022-09-28 |
| NCT03554772 | Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15 | COMPLETED | PHASE2 | 2018-06-19 | 2018-08-20 | 2018-08-20 |
| NCT03421197 | A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) | COMPLETED | PHASE2 | 2018-01-25 | 2020-03-30 | 2020-03-30 |
| NCT03599193 | A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris | COMPLETED | PHASE2 | 2017-10-04 | 2018-04-30 | 2018-04-30 |
| NCT03340961 | A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules | COMPLETED | PHASE2 | 2017-10-01 | 2019-03-31 | 2018-11-07 |
| NCT03341910 | A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris | COMPLETED | PHASE2 | 2017-08-21 | 2018-05-18 | 2018-05-18 |
| NCT03290027 | A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris | COMPLETED | PHASE3 | 2017-07-31 | 2018-04-19 | 2018-04-19 |
| NCT03292640 | A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks | COMPLETED | PHASE3 | 2017-07-06 | 2018-05-14 | 2018-05-14 |
| NCT03282838 | Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects | COMPLETED | PHASE1 | 2017-06-09 | 2018-01-12 | 2017-08-22 |
| NCT03160807 | Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections | UNKNOWN | PHASE4 | 2017-04-15 | 2018-03 | 2018-03 |
| NCT03116698 | A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period | COMPLETED | PHASE2, PHASE3 | 2017-02-14 | 2018-07-05 | 2017-11-13 |
| NCT02828241 | A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 | COMPLETED | PHASE2 | 2016-07 | 2017-11 | 2017-01 |
| NCT03702855 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions | COMPLETED | PHASE1 | 2015-12 | 2015-12 | 2015-12 |
| NCT03696329 | Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2015-10 | 2015-11 | 2015-11 |
| NCT02569853 | DFN-11 Injection in Episodic Migraine With or Without Aura | COMPLETED | PHASE3 | 2015-09-21 | 2018-02-26 | 2017-05-30 |
| NCT02583425 | Pilot Study of DFN-11 Injection in Medication Overuse Headache | TERMINATED | PHASE2 | 2015-09 | 2016-11 | 2016-08 |
| NCT02571049 | Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine | COMPLETED | PHASE2 | 2015-09 | 2016-05 | 2016-04 |
| NCT02572986 | A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies | COMPLETED | PHASE3 | 2015-09 | 2016-08 | 2016-06 |
| NCT02301962 | Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer | UNKNOWN | PHASE4 | 2015-07-28 | 2022-01-31 | 2021-06-30 |
| NCT03051685 | Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults | COMPLETED | PHASE1 | 2015-07-20 | 2015-11-10 | 2015-08-14 |
| NCT02472418 | Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches | COMPLETED | PHASE2 | 2015-06-05 | 2016-05-05 | 2015-12-01 |
| NCT03706300 | Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2014-12 | 2015-01 | 2015-01 |
| NCT02296775 | Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE1, PHASE2 | 2014-11 | 2017-10-05 | 2016-11 |
| NCT02279082 | DFN-02 Open Label Safety Study in Patients With Acute Migraine | COMPLETED | PHASE3 | 2014-09 | 2016-03 | 2015-09 |
| NCT02260544 | Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | COMPLETED | PHASE1 | 2014-07 | 2015-08 | 2015-04 |
| NCT02173301 | A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis | COMPLETED | PHASE2 | 2014-06 | 2015-08 | 2015-05 |
| NCT02097485 | Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation | COMPLETED | PHASE2 | 2014-05 | 2014-10 | 2014-09 |
| NCT02060903 | A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation | COMPLETED | PHASE3 | 2014-02 | 2014-08 | 2014-07 |
| NCT02062060 | Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation | COMPLETED | PHASE3 | 2014-02 | 2014-08 | 2014-07 |
| NCT02205320 | A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers | UNKNOWN | PHASE1 | 2014-02 | 2014-09 | 2014-08 |
| NCT02061813 | Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion | COMPLETED | PHASE1 | 2014-01 | 2014-05 | 2014-01 |
| NCT02062073 | Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion | COMPLETED | PHASE1 | 2014-01 | 2014-06 | 2014-03 |
| NCT01888367 | Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery | COMPLETED | PHASE2 | 2013-10 | 2015-02 | 2015-02 |
| NCT02010333 | A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation | COMPLETED | PHASE2 | 2013-04 | 2014-08 | 2014-07 |
| NCT01907490 | Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation | COMPLETED | PHASE2 | 2013-03 | 2013-12 | 2013-07 |
| NCT02638831 | Ketorol Gel in Gonarthrosis and Low Back Pain | COMPLETED | PHASE4 | 2013-03 | 2013-11 | 2013-11 |
| NCT02922699 | Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases | COMPLETED | PHASE4 | 2013-01 | 2013-06 | 2013-06 |
| NCT02322619 | Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2012-11 | 2012-12 | 2012-12 |
| NCT01674530 | Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation | COMPLETED | PHASE3 | 2012-10 | 2014-03 | 2014-01 |
| NCT01559545 | A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis | COMPLETED | PHASE2 | 2012-03 | 2013-03 | 2013-02 |
| NCT01496352 | DFA-02 in Patients Undergoing Colorectal Surgery | COMPLETED | PHASE1, PHASE2 | 2012-02 | 2013-06 | 2013-04 |
| NCT01518699 | Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers | COMPLETED | PHASE1 | 2012-01 | 2012-05 | 2012-05 |
| NCT02295046 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition | COMPLETED | PHASE1 | 2011-10 | 2011-11 | 2011-10 |
| NCT02292069 | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition | COMPLETED | PHASE1 | 2011-09 | 2011-10 | 2011-09 |
| NCT01503424 | Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study | COMPLETED | PHASE1 | 2011-08 | 2011-09 | 2011-09 |
| NCT01503398 | Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2011-08 | 2011-09 | 2011-09 |
| NCT01388816 | A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels | COMPLETED | PHASE2 | 2011-07 | 2012-06 | 2012-05 |
| NCT02296723 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed Condition | COMPLETED | PHASE1 | 2011-07 | 2011-08 | 2011-07 |
| NCT02297854 | Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition | COMPLETED | PHASE1 | 2011-07 | 2011-08 | 2011-07 |
| NCT01888224 | Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition | COMPLETED | PHASE1 | 2011-06 | 2011-07 | 2011-06 |
| NCT01336647 | An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation | COMPLETED | PHASE2 | 2011-04 | 2012-03 | 2011-08 |
| NCT02922712 | Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis) | COMPLETED | PHASE4 | 2011-03 | 2013-08 | 2013-06 |
| NCT01888718 | Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition | COMPLETED | PHASE1 | 2011-02 | 2011-03 | 2011-02 |
| NCT01691456 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition | COMPLETED | PHASE1 | 2011-01 | 2011-02 | 2011-01 |
| NCT01691469 | Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition | COMPLETED | PHASE1 | 2011-01 | 2011-02 | 2011-01 |
| NCT01581788 | Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions | COMPLETED | PHASE1 | 2011-01 | 2011-03 | 2011-02 |
| NCT01581775 | Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2011-01 | 2011-03 | 2011-01 |
| NCT01694797 | Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition | COMPLETED | PHASE1 | 2011-01 | 2011-01 | 2011-01 |
| NCT01673997 | Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2010-12 | 2011-01 | 2011-01 |
| NCT02322632 | Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions | COMPLETED | PHASE1 | 2010-11 | 2011-02 | 2010-12 |
| NCT01923259 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition | COMPLETED | PHASE1 | 2010-10 | 2010-12 | 2010-10 |
| NCT01923558 | Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-10 | 2010-11 | 2010-10 |
| NCT01888757 | Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition | COMPLETED | PHASE1 | 2010-09 | 2010-10 | 2010-09 |
| NCT01888731 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-08 | 2010-09 | 2010-08 |
| NCT01888250 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-08 | 2010-09 | 2010-08 |
| NCT01888263 | Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition | COMPLETED | PHASE1 | 2010-08 | 2010-09 | 2010-08 |
| NCT01645449 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2010-06 | 2010-08 | 2010-08 |
| NCT01566487 | Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-06 | 2010-06 | 2010-06 |
| NCT01674517 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition | COMPLETED | PHASE1 | 2010-02 | 2010-02 | 2010-02 |
| NCT01671709 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-02 | 2010-03 | 2010-03 |
| NCT01671722 | Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition | COMPLETED | PHASE1 | 2010-02 | 2010-03 | 2010-03 |
| NCT02296762 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition | COMPLETED | PHASE1 | 2010-02 | 2010-02 | 2010-02 |
| NCT01674504 | Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-01 | 2010-01 | 2010-01 |
| NCT02296749 | Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition | COMPLETED | PHASE1 | 2010-01 | 2010-02 | 2010-01 |
| NCT01627834 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition | COMPLETED | PHASE1 | 2009-10 | 2009-11 | 2009-10 |
| NCT01627847 | Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition | COMPLETED | PHASE1 | 2009-10 | 2009-11 | 2009-10 |
| NCT01504516 | Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition | COMPLETED | PHASE1 | 2009-10 | 2009-12 | 2009-11 |
| NCT01504503 | Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition | COMPLETED | PHASE1 | 2009-10 | 2009-12 | 2009-11 |
| NCT01645423 | Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2009-08 | 2009-09 | 2009-09 |
| NCT01645384 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2009-05 | 2009-07 | 2009-06 |
| NCT01645410 | Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2009-03 | 2009-05 | 2009-04 |
| NCT01513057 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed Conditions | COMPLETED | PHASE1 | 2009-01 | 2009-02 | 2009-01 |
| NCT01513044 | Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting Conditions | COMPLETED | PHASE1 | 2009-01 | 2009-01 | 2009-01 |
| NCT01270308 | Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions | COMPLETED | PHASE1 | 2008-12 | 2008-12 | 2008-12 |
| NCT02322658 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed Conditions | COMPLETED | PHASE1 | 2008-09 | 2008-10 | 2008-09 |
| NCT01627886 | Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition | COMPLETED | PHASE1 | 2008-09 | 2008-10 | 2008-09 |
| NCT01621763 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions | COMPLETED | PHASE1 | 2008-09 | 2008-09 | 2008-09 |
| NCT02322645 | Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2008-08 | 2008-10 | 2008-08 |
| NCT01621750 | Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2008-08 | 2008-09 | 2008-09 |
| NCT01155947 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2008-05 | 2008-07 | 2008-06 |
| NCT01155960 | Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2008-05 | 2008-07 | 2008-06 |
| NCT02291367 | Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition | COMPLETED | PHASE1 | 2008-05 | 2008-05 | 2008-05 |
| NCT02291341 | Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition | COMPLETED | PHASE1 | 2008-05 | 2008-05 | 2008-05 |
| NCT01372982 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2008-04 | 2008-06 | 2008-06 |
| NCT01053208 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition | COMPLETED | PHASE1 | 2008-04 | 2008-04 | 2008-04 |
| NCT01053338 | Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition | COMPLETED | PHASE1 | 2008-04 | 2008-04 | 2008-04 |
| NCT01375452 | Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2008-03 | 2008-05 | 2008-05 |
| NCT01506063 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2008-01 | 2008-01 | 2008-01 |
| NCT01132027 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions | COMPLETED | PHASE1 | 2008-01 | 2008-03 | 2008-02 |
| NCT01131988 | Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2008-01 | 2008-03 | 2008-02 |
| NCT01506076 | Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2007-12 | 2008-01 | 2008-01 |
| NCT01283061 | Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | COMPLETED | PHASE1 | 2007-12 | 2008-01 | 2008-01 |
| NCT01283841 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2007-11 | 2007-12 | 2007-12 |
| NCT01283867 | Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions | COMPLETED | PHASE1 | 2007-11 | 2007-12 | 2007-12 |
| NCT01133483 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr.Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2007-04 | 2007-05 | 2007-04 |
| NCT01506011 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2007-03 | 2007-04 | 2007-04 |
| NCT01505998 | Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2007-03 | 2007-05 | 2007-05 |
| NCT01136538 | Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2007-02 | 2007-05 | 2007-02 |
| NCT01133470 | Bioequivalence Study of Fexofenadine HCl 180 mg + Pseudoephedrine HCl 240 mg ER Tablets of Dr. Reddy's and Allegra D 24 Hour ER Tablets Under Fasting Conditions | COMPLETED | PHASE1 | 2007-02 | 2007-04 | 2007-02 |
| NCT01136525 | Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2007-02 | 2007-05 | 2007-03 |
| NCT01132183 | Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce) | COMPLETED | PHASE1 | 2007-02 | 2007-03 | 2007-03 |
| NCT01159158 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | COMPLETED | PHASE1 | 2007-02 | 2007-02 | 2007-02 |
| NCT01133496 | Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-12 | 2007-04 | 2006-12 |
| NCT01045642 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions | COMPLETED | PHASE1 | 2006-12 | 2007-03 | 2006-12 |
| NCT01056627 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition | COMPLETED | PHASE1 | 2006-12 | 2007-03 | 2007-01 |
| NCT01045434 | Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions | COMPLETED | PHASE1 | 2006-12 | 2007-03 | 2007-01 |
| NCT01055938 | Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2006-12 | 2007-03 | 2007-01 |
| NCT01503437 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition | COMPLETED | PHASE1 | 2006-11 | 2006-12 | 2006-11 |
| NCT01503450 | Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition | COMPLETED | PHASE1 | 2006-11 | 2006-12 | 2006-12 |
| NCT01264302 | Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions | COMPLETED | PHASE1 | 2006-11 | 2006-11 | 2006-11 |
| NCT01264289 | Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions | COMPLETED | PHASE1 | 2006-11 | 2006-11 | 2006-11 |
| NCT01512485 | Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed Conditions | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT01064232 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT01064271 | Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT01511705 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fasting Condition | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT01511718 | Bioequivalence Study for Ondansetron Hydrochloride Tablets 8 mg Under Fed Condition | COMPLETED | PHASE1 | 2006-10 | 2006-10 | 2006-10 |
| NCT01267383 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed Conditions | COMPLETED | PHASE1 | 2006-09 | 2006-10 | 2006-09 |
| NCT01267396 | Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2006-09 | 2006-10 | 2006-09 |
| NCT01506713 | Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-09 | 2006-09 | 2006-09 |
| NCT01132196 | Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2006-08 | 2006-11 | 2006-09 |
| NCT01132170 | Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-08 | 2006-11 | 2006-09 |
| NCT01132040 | Bioequivalence Study of Primidone Tablets 50 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-08 | 2006-09 | 2006-09 |
| NCT01512459 | Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions | COMPLETED | PHASE1 | 2006-05 | 2006-06 | 2006-05 |
| NCT01052129 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition | COMPLETED | PHASE1 | 2006-05 | 2006-05 | 2006-05 |
| NCT01052792 | Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions | COMPLETED | PHASE1 | 2006-05 | 2006-06 | 2006-05 |
| NCT01506791 | Bioequivalence Study of Desloratadine and Pseudoephedrine Extended-release Tablets Under Fed Conditions | COMPLETED | PHASE1 | 2006-04 | 2006-04 | |
| NCT01373138 | Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions | COMPLETED | PHASE1 | 2006-04 | 2006-05 | |
| NCT01164787 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-03 | 2006-05 | 2006-04 |
| NCT01164800 | Bioequivalence Study of Trandolapril 4 mg Tablets of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2006-03 | 2006-05 | 2006-04 |
| NCT01164813 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2006-03 | 2006-03 | 2006-03 |
| NCT01164826 | Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2006-03 | 2006-03 | 2006-03 |
| NCT01166100 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2006-02 | 2006-08 | 2006-03 |
| NCT01166087 | Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2006-02 | 2006-09 | 2006-03 |
| NCT01170182 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition | COMPLETED | PHASE1 | 2006-02 | 2006-04 | 2006-04 |
| NCT01170169 | Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions | COMPLETED | PHASE1 | 2006-01 | 2006-03 | 2006-03 |
| NCT01064102 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT01064115 | Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2006-01 | 2006-02 | 2006-01 |
| NCT01506037 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fed Condition | COMPLETED | PHASE1 | 2006-01 | 2006-02 | |
| NCT01506050 | Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition | COMPLETED | PHASE1 | 2006-01 | 2006-02 | |
| NCT01314352 | Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2005-12 | 2006-03 | 2005-12 |
| NCT01314339 | Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions. | COMPLETED | PHASE1 | 2005-12 | 2006-02 | 2005-12 |
| NCT01164774 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions | COMPLETED | PHASE1 | 2005-10 | 2005-11 | 2005-10 |
| NCT01164761 | Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2005-09 | 2005-10 | 2005-09 |
| NCT01269281 | Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions | COMPLETED | PHASE1 | 2005-07 | 2005-07 | 2005-07 |
| NCT01155908 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions | COMPLETED | PHASE1 | 2005-04 | 2005-05 | 2005-05 |
| NCT01372345 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2005-02 | 2005-03 | 2005-02 |
| NCT01160068 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fed Condition | COMPLETED | PHASE1 | 2005-02 | 2005-05 | 2005-05 |
| NCT01372358 | Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions | COMPLETED | PHASE1 | 2005-01 | 2005-02 | 2005-01 |
| NCT01167894 | Bioequivalence Study of Simvastatin Tablets 80 mg of Dr. Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2005-01 | 2005-04 | 2005-04 |
| NCT01167933 | Bioequivalence Study of Simvastatin Tablets, 80 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2005-01 | 2005-04 | 2005-04 |
| NCT01161966 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2005-01 | 2005-03 | 2005-02 |
| NCT01160042 | Bioequivalence Study of Metformin Hydrochloride Tablets 1000 mg Tablets of Dr. Reddy's Laboratories Limited Under Fasting Condition | COMPLETED | PHASE1 | 2005-01 | 2005-04 | 2005-04 |
| NCT01161979 | Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | COMPLETED | PHASE1 | 2005-01 | 2005-03 | 2005-02 |
| NCT01581866 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2004-11 | 2005-01 | 2004-11 |
| NCT01581879 | Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2004-11 | 2005-01 | 2004-11 |
| NCT01372280 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2004-10 | 2004-11 | 2004-10 |
| NCT01283932 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition | COMPLETED | PHASE1 | 2004-10 | 2004-12 | 2004-12 |
| NCT01283919 | Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | COMPLETED | PHASE1 | 2004-10 | 2004-12 | 2004-12 |
| NCT01131780 | Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2004-10 | 2004-11 | 2004-10 |
| NCT01372306 | Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2004-10 | 2004-11 | 2004-11 |
| NCT01160029 | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition | COMPLETED | PHASE1 | 2004-10 | 2004-10 | 2004-10 |
| NCT01161147 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition | COMPLETED | PHASE1 | 2004-10 | 2004-12 | 2004-12 |
| NCT01132222 | Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions | COMPLETED | PHASE1 | 2004-09 | 2004-10 | 2004-10 |
| NCT01161134 | Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition | COMPLETED | PHASE1 | 2004-09 | 2004-11 | 2004-11 |
| NCT01155921 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2004-08 | 2004-08 | 2004-08 |
| NCT01155934 | Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | COMPLETED | PHASE1 | 2004-08 | 2004-08 | 2004-08 |
| NCT01161940 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2004-07 | 2004-09 | 2004-09 |
| NCT01161927 | Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions | COMPLETED | PHASE1 | 2004-07 | 2004-09 | 2004-09 |
| NCT01131767 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2004-07 | 2004-09 | 2004-08 |
| NCT01131728 | Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2004-07 | 2004-09 | 2004-08 |
| NCT01155895 | Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2004-03 | 2004-04 | 2004-03 |
| NCT01146041 | Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2004-02 | 2004-04 | 2004-02 |
| NCT01146067 | Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions | COMPLETED | PHASE1 | 2004-01 | 2004-02 | 2004-02 |
| NCT01053689 | Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition | COMPLETED | PHASE1 | 2003-12 | 2003-12 | 2003-12 |
| NCT01052909 | Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition | COMPLETED | PHASE1 | 2003-12 | 2003-12 | 2003-12 |
| NCT01149967 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions | COMPLETED | PHASE1 | 2003-10 | 2003-11 | 2003-11 |
| NCT01149980 | Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions | COMPLETED | PHASE1 | 2003-10 | 2003-11 | 2003-11 |
| NCT01132352 | Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2003-09 | 2003-11 | 2003-10 |
| NCT01131897 | Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions. | COMPLETED | PHASE1 | 2003-09 | 2003-11 | 2003-09 |
| NCT01149954 | Bioequivalence Study of Ibuprofen 200 mg Soft Gel Capsules of Dr. Reddy's Laboratories Limited Under Fed Conditions | COMPLETED | PHASE1 | 2003-01 | 2003-01 | 2003-01 |
| NCT01131949 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fasting Condition | COMPLETED | PHASE1 | 2003-01 | 2003-03 | 2003-02 |
| NCT01131702 | Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2003-01 | 2003-03 | 2003-02 |
| NCT01131975 | Bioequivalence Study of Lamotrigine 25 mg Chewable Tablets of Dr.Reddy's Under Fed Condition | COMPLETED | PHASE1 | 2003-01 | 2003-03 | 2003-02 |
| NCT01146106 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2002-12 | 2002-12 | 2002-12 |
| NCT01513720 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fasting Condition | COMPLETED | PHASE1 | 2002-12 | 2002-12 | 2002-12 |
| NCT01146093 | Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions | COMPLETED | PHASE1 | 2002-11 | 2003-03 | 2002-11 |
| NCT01149941 | Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition | COMPLETED | PHASE1 | 2002-11 | 2002-11 | 2002-11 |
| NCT01513681 | Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition | COMPLETED | PHASE1 | 2002-11 | 2002-11 | 2002-11 |
| NCT01131923 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2002-10 | 2002-12 | 2002-11 |
| NCT01511770 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions | COMPLETED | PHASE1 | 2002-08 | 2002-09 | 2002-08 |
| NCT01131936 | Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2002-08 | 2002-11 | 2002-09 |
| NCT01888341 | Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting Condition | COMPLETED | PHASE1 | 2002-08 | 2002-08 | 2002-08 |
| NCT01511757 | Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions | COMPLETED | PHASE1 | 2002-06 | 2002-07 | 2002-06 |
| NCT01064180 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions | COMPLETED | PHASE1 | 2002-05 | 2002-05 | 2002-05 |
| NCT01064154 | Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fasting Conditions | COMPLETED | PHASE1 | 2002-05 | 2002-05 | 2002-05 |
| NCT01133444 | Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition | COMPLETED | PHASE1 | 2002-04 | 2002-05 | 2002-04 |
| NCT01066754 | Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions | COMPLETED | PHASE1 | 2002-04 | 2002-05 | 2002-05 |
| NCT01066767 | Bioequivalence Study of Dr. Reddy's Laboratories Limited Fexofenadine Hydrochloride 180 mg Tablets Under Fed Conditions | COMPLETED | PHASE1 | 2002-04 | 2002-05 | 2002-05 |
| NCT01133457 | Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition | COMPLETED | PHASE1 | 2002-04 | 2002-05 | 2002-05 |
| NCT01286701 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2002-01 | 2002-03 | 2002-02 |
| NCT01286688 | Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions | COMPLETED | PHASE1 | 2002-01 | 2002-03 | 2002-02 |
| NCT01146028 | Bioequivalence Study of Tizanidine HCl Tablets 4 mg of Dr.Reddys Under Fasting Conditions | COMPLETED | PHASE1 | 2001-09 | 2001-11 | 2001-09 |
| NCT01065987 | Bioequivalence Study of Tizanidine HCl 4mg Tablets of Dr.Reddy's Under Fed Conditions | COMPLETED | PHASE1 | 2001-09 | 2001-11 | 2001-09 |
| NCT01888289 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition | COMPLETED | PHASE1 | 2001-07 | 2001-09 | 2001-08 |
| NCT01888328 | Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed Condition | COMPLETED | PHASE1 | 2001-05 | 2001-06 | 2001-05 |
| NCT01511731 | Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions | COMPLETED | PHASE1 | 1998-10 | 1998-10 | 1998-10 |